Potassium Channel Opener

Advertisement

cGxPJobs Banner

.Clinical Pharma

Zhimeng Biopharma Wins Approval to Launch Phase 2 Epilepsy Trial

Shanghai, China – September 11, 2025 – Shanghai Zhimeng Biopharma, Inc. today announced that its investigational therapy CB03-154, a...

By cGxPwire Editor
September 11, 2025

Read More

Advertisement

cGxPJobs

Directory